This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at 1-888-411-7578.
Patient Groups such as HepCBC provide patient input to the Canadian Agency for Drugs and Technologies in Health (CADTH) and the Canadian Drug Review (CDR) which helps them determine whether they should approve drugs for use in Canada, and what restrictions and criteria should be applied to their use. Here are some new (SHORT but GREAT!) YouTube videos which show why this input is so critical, and how it is used to benefits patients such as US! CLICK HERE to VIEW. https://www.youtube.com/watch?v=kop9yWq6tN0&index=1&list=PL45wcLqNa3c6sYRD7XLM9akLF3y6dbz3W And…after you watch these videos, please take a few minutes to fill out our most recent request for hepatitis C patient input, which will be used to determine if the AbbVie 3-drug combo will be approved for use by Canadian HCV patients. To access this, CLICK HERE. http://hepcbc.bchep.org/2014/11/urgent-request-patient-input-interferon-free-hcv-3-drug-combo-abbvie/
THANKS!!